|
|
Article: Bay City Capital Acquires 2.48 Million Shares of Axys Pharmaceuticals Common Stock.
- Article from:
- Business Wire
- Article date:
- March 16, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Health/Medical Writers
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--March 16, 2001
Axys Pharmaceuticals, Inc. (Nasdaq: AXPH) announced today that Bay City Capital, acting through its funds Bay City Capital Fund I, LLC (BCC) and The North American Nutrition & Agribusiness Fund L.P. (NANAF), have acquired a total of 2,482,758 shares of Axys common stock through the exercise of options.
Those options had been granted in connection with the BCC and NANAF funding of Akkadix Corporation (Akkadix), an agricultural biotechnology company founded in June 1998 by BCC and Axys. As a result of the exercise of these options, Axys has acquired an additional ...